NCT01357525View on ClinicalTrials.gov

SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 6, 2013

Primary Completion Date

April 1, 2018

Study Completion Date

June 1, 2018

Conditions
Adenocarcinoma of the Pancreas
Interventions
RADIATION

Stereotactic Body Radiation Therapy (SBRT)

"An SBRT plan will be created by a medical physicist based on the PTV contoured on the CT scan. The plan will be to deliver fractionated SBRT to the isodose line best encompassing the PTV:~12 Gy x 3 fractions (36 Gy total)"

Trial Locations (1)

15232

UPMC Hillman Cancer Center, Pittsburgh

All Listed Sponsors
lead

David A. Clump, MD, PhD

OTHER

NCT01357525 - SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter